Yet more drug news (walking-specific, this time) for people with MS

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts.

It’s been a big drug news week for people with multiple sclerosis. Today, the Food and Drug Administration approved the first medication specifically to improve walking skills in people with MS.

‘In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo)],’ the FDA announcement stated. One would hope so.

Here’s the announcement from the FDA.

And here’s information from the National Multiple Sclerosis Society on the walking problems that people with MS experience. Physical therapy can help, but often not enough.

In other MS drug news this week, two new drugs are looking promising as potential oral treatments: Haunted by Tysabri, but looking ahead to MS drugs of the future

-- Tami Dennis